Search

Department of Pharmacology

Pharmacology is a broad and integrative discipline that focuses on the interaction of living cells with the regulatory molecules in their environment. It is a diverse science that proves basic mechanisms of molecular and cellular function with the knowledge that unraveling these mechanisms will lead to new therapeutic approaches to a variety of diseases. The Department of Pharmacology has a unique role within the basic biomedical sciences: to conduct investigations into the fundamental principles of cell function and translate these findings to clinical applications.

Our faculty offer a variety of exciting research opportunities in Cellular and Molecular Pharmacology, including the following Research Interests:

  • Cardiovascular/Respiratory Biology
  • Cellular Physiology
  • Chemical Biology and Molecular Pharmacology
  • Immunity and Inflammation
  • Metabolism
  • Molecular and Systems Neuroscience

 

Congratulations to Norbert Leitinger!

Congratulations to Norbert Leitinger on being honored at the 2025 Faculty Awards Ceremony! A huge honor!

Read More

RIM Michelle Bland

Research in Motion: Michelle Bland, PhD

Department of Pharmacology's Dr. Michelle Bland has been featured in this week's Research in Motion

Read More

Congratulations Richard Mailman!

Dr. Richard Mailman has spent decades working to get the Parkinson’s drug Tavapadon to patients. After tireless effort, the pharmaceutical company AbbVie has finally submitted the drug to the FDA for consideration. This is great news, because it has been over 50 years since a Parkinson’s drug has been approved. Tavapadon has the potential to improve the lives of so many people.

Read more

Explore the UVA BIMS Program

Our distinguished faculty and cutting-edge curriculum empower future leaders in biomedical research to tackle today's complex challenges with passion and expertise.

Our deadline for Fall 2024 admission was December 1, 2023, and applications are currently under review. The application portal will open on September 1, 2024, for Fall 2025 admission.

More Information

News All News »

Congratulations to Dr. Richard Mailman

Dr. Richard Mailman has spent decades working to get the Parkinson’s drug Tavapadon to patients. After tireless effort, the pharmaceutical company AbbVie has finally submitted the drug to the FDA…

Bland Lab Has a New Paper Published in PNAS

The Bland Lab has a new paper published in PNAS, The insulin-like peptides Dilp2 and Dilp6 exhibit divergent responses to dietary sugar and protein in Drosophila larvae. Their results suggest…

Doug Bayliss, PhD, Earns $2.8 Million NIH Grant to Study the CO₂ Sensing Mechanisms That Control Breathing

Doug Bayliss, PhD, the Joseph & Frances Larner Professor, and his research group in the Department of Pharmacology, were awarded a new four-year $2.8 million grant from the National Heart…

Dr.’s Ling Qi and Shengyi Sun Publish New Research in Nature Cell Biology

A newly published review in Nature Cell Biology by Drs. Ling Qi and Shengyi Sun, along with postdoctoral fellow Dr. Huilun Helen Wang and collaborator Dr. Ida Biunno, provides a…